|
January
2010
Investigating the role of muscle stem
cells in Facioscapulohumeral muscular dystrophy
Does perturbed satellite cell function contribute
to facioscapulohumeral muscular dystrophy? A study by Dr Peter Zammit
at Kings Colledge London.(Courtesy of Muscular Dystrophy Campaign) Read
more
December
20th 2009
Epidemiology and
pathophysiology of falls in Facioscapulohumeral disease
Muscle
weakness is a potentially important, yet poorly studied, risk factor
for falls. Detailed studies of patients with specific myopathies may
shed new light on the relation between muscle weakness and falls. Here
falls in patients with facioscapulohumeral disease (FSHD) who suffered
from lower limb muscle weakness were examined. This study provides insights
into the prevalence, relevance and pathophysiology of falls in FSHD.
Read
more
Further information for patients is also available pdf
December
20th 2009
Effects of an antioxidant supplementation
on oxidative stress and muscle dysfunction in FSH-MD patients
The purpose of this study was to gain
futher insights into the specific targets of endogenously generated
mitochondrial oxidative stress in the FSHD skeletal muscle
and to test whether or not an antioxidant supplementation has a therapeutic
interest
for FSHD patients. Our results have important implications for the successful
implementation of rational antioxidant therapy in FSHD in which cell
loss could be
linked to mitochondrial dysfunction and oxidative stress. Read
more
December
2009
Latest from Target Research magazine
Contains news from the latest issue
of Target Research magazine published by the Muscular Dystrophy Campaign.(Courtesy
of Muscular Dystrophy Campaign) Read
more
November
19th 2009
Gene therapy may be used to treat muscular dystrophy
A gene therapy that
increases the size and strength of muscle tissue could soon be used
to treat neuromuscular disorders such as muscular dystrophy, according
to scientists. In
a study on monkeys, the treatment, which modifies the body’s natural
regulation of muscle growth, was found to have long-lasting effects
on muscle mass and tone. Read
more
November
2009
Improving quality of life for people
with muscle disease
Study into changing advrse beliefs
in those with muscle disease, lead by Prof John Weinman at Kings College
London.(Courtesy of Muscular Dystrophy Campaign) Read
more
October
2009
Understanding the molecular causes
of Facioscapulohumeral muscular dystrophy
Investigation
of molecular mechanisms in facioscapulohumeral muscular dystrophy lead
by Prof. Jane Hewitt at the University of Nottingham. (Courtesy of Muscular
Dystrophy Campaign) Read
more
Autumn
2009
Chronic pain in people with FSH-MD
Recent preliminary
research suggests that pain may be a significant problem for many persons
with FSHD. For example, Bushby et al. recently reported on four individuals
with FSHD who identified pain as their most disabling symptom Read
more (courtesy of the FSH Society)
April
28th 2009
Researchers identify gene associated
with muscular dystrophy related eye problems
Skeletal muscle
disease and vision deficits might seem unrelated, but a frog model of
muscular dystrophy shows it is not such a leap. Read
more
|
